The Scotts Miracle-Gro financials
$49.50+2.19%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Sep 30 | FY24 Sep 30 | FY23 Sep 30 | FY22 Sep 30 | FY21 Sep 30 | FY20 Sep 30 | FY19 Sep 30 | FY18 Sep 30 | FY17 Sep 30 | FY16 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.41B | $3.55B | $3.55B | $3.92B | $4.92B | $4.13B | $3.16B | $2.66B | $2.64B | $2.51B |
| Gross profit | $1.04B | $850.5M | $657.3M | $872.9M | $1.47B | $1.35B | $1.02B | $864.6M | $972.6M | $900.3M |
| Gross margin | 30.6% | 23.9% | 18.5% | 22.2% | 29.8% | 32.6% | 32.3% | 32.5% | 36.8% | 35.9% |
| Operating income | $377.4M | $228.7M | -$174.5M | -$434.0M | $723.0M | $570.1M | $409.6M | $198.9M | $433.4M | $447.6M |
| Net income | $145.2M | -$34.9M | -$380.1M | -$437.5M | $512.5M | $387.4M | $460.7M | $63.7M | $218.3M | $315.3M |
| Net margin | 4.3% | −1.0% | −10.7% | −11.1% | 10.4% | 9.4% | 14.6% | 2.4% | 8.3% | 12.6% |
| Diluted EPS | $2.47 | $-0.61 | $-6.79 | $-7.88 | $8.96 | $6.81 | $8.18 | $1.12 | $3.63 | $5.09 |
| EBITDA | $515.8M | $372.1M | $198.5M | $364.3M | $821.1M | $665.6M | $506.3M | $414.6M | $518.4M | $469.6M |
| Operating cash flow | $371.3M | $667.5M | $531.0M | -$129.0M | $271.5M | $558.0M | $226.8M | $307.1M | $420.6M | $438.1M |
| Free cash flow | $273.9M | $583.5M | $438.2M | -$242.5M | $164.6M | $495.3M | $184.4M | $238.9M | $351.0M | $379.8M |
| Diluted shares | 58.7M | 56.8M | 56.0M | 55.5M | 57.2M | 56.9M | 56.3M | 57.1M | 60.2M | 62.0M |
Balance sheet
| Period end | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $32.8M | $71.6M | $31.9M | $86.8M | $244.1M | $16.6M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Total debt | $2.11B | $2.23B | $2.61B | $2.97B | $2.29B | $1.52B |
| Total assets | $2.74B | $2.87B | $3.41B | $4.30B | $4.80B | $3.38B |
| Total liabilities | $3.10B | $3.26B | $3.68B | $4.15B | $3.79B | $2.68B |
| Shareholders' equity | -$357.5M | -$390.6M | -$267.3M | $147.7M | $1.01B | $702.9M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology